Hidden biases in an observational study of bevacizumab beyond progression.
Publication
, Journal Article
Kopetz, S; Abbruzzese, JL
Published in: J Clin Oncol
April 1, 2009
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
April 1, 2009
Volume
27
Issue
10
Start / End Page
1732 / 1733
Location
United States
Related Subject Headings
- Practice Patterns, Physicians'
- Oncology & Carcinogenesis
- Epidemiologic Research Design
- Disease Progression
- Colorectal Neoplasms
- Bias
- Bevacizumab
- Antineoplastic Agents
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal
Citation
APA
Chicago
ICMJE
MLA
NLM
Kopetz, S., & Abbruzzese, J. L. (2009). Hidden biases in an observational study of bevacizumab beyond progression. J Clin Oncol, 27(10), 1732–1733. https://doi.org/10.1200/JCO.2009.21.2084
Kopetz, Scott, and James L. Abbruzzese. “Hidden biases in an observational study of bevacizumab beyond progression.” J Clin Oncol 27, no. 10 (April 1, 2009): 1732–33. https://doi.org/10.1200/JCO.2009.21.2084.
Kopetz S, Abbruzzese JL. Hidden biases in an observational study of bevacizumab beyond progression. J Clin Oncol. 2009 Apr 1;27(10):1732–3.
Kopetz, Scott, and James L. Abbruzzese. “Hidden biases in an observational study of bevacizumab beyond progression.” J Clin Oncol, vol. 27, no. 10, Apr. 2009, pp. 1732–33. Pubmed, doi:10.1200/JCO.2009.21.2084.
Kopetz S, Abbruzzese JL. Hidden biases in an observational study of bevacizumab beyond progression. J Clin Oncol. 2009 Apr 1;27(10):1732–1733.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
April 1, 2009
Volume
27
Issue
10
Start / End Page
1732 / 1733
Location
United States
Related Subject Headings
- Practice Patterns, Physicians'
- Oncology & Carcinogenesis
- Epidemiologic Research Design
- Disease Progression
- Colorectal Neoplasms
- Bias
- Bevacizumab
- Antineoplastic Agents
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal